Averion, Trio Clinical Research, Fulcrum Pharma and ClinResearch/ADDPLAN have merged into a new global biopharmaceutical and medical device development services organization. The merger, led by a group of investors including The Halifax Group, SV Life Sciences and the Comvest Group, is part of a strategy to address the pressures and challenges currently facing the pharmaceutical, biotech, and medical device industry through an integrated service offering. Patrick K. Donnelly, formerly the chi...